Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 38,939	$ (150,262)	$ 14,516
Adjustments to reconcile net income (loss) to net cash provided by operations:
(Gain) loss on divestitures	(2,176)	195,729	0
Impairments and other non-cash charges	0	0	6,356
Depreciation and amortization	25,537	27,530	31,372
Stock-based compensation expense	5,527	5,247	6,638
Provision for deferred income taxes	8,923	(20,304)	(482)
Credit loss expense	35	698	1,209
Gain on sale of assets	(1,864)	(4,297)	(2,904)
Gain on insurance recovery	0	(874)	0
Amortization of original issue discount and debt issuance costs	472	983	541
Change in assets and liabilities:
(Increase) decrease in receivables	(3,921)	(28,012)	64,812
Decrease in inventories	3,377	9,746	2,256
(Increase) decrease in other assets	(3,521)	(3,913)	307
Increase (decrease) in accounts payable	(2,576)	12,488	(25,065)
Increase (decrease) in accrued liabilities and other	4,236	(6,590)	445
Net cash provided by operating activities	72,988	38,169	100,001
Cash flows from investing activities:
Capital expenditures	(46,671)	(43,531)	(29,232)
Business acquisitions, net of cash acquired	(42,352)	0	0
Proceeds from divestitures, net of cash disposed	16,603	48,499	19,833
Proceeds from sale of property, plant and equipment	4,014	4,997	3,709
Proceeds from insurance property claim	0	1,385	0
Other investing activities	3,089	(3,089)	0
Net cash provided by (used in) investing activities	(65,317)	8,261	(5,690)
Cash flows from financing activities:
Borrowings on lines of credit	27,300	177,541	241,873
Payments on lines of credit	(22,000)	(224,292)	(277,591)
Debt issuance costs	(1,241)	(50)	0
Purchases of treasury stock	(22,695)	(4,505)	(34,265)
Proceeds from employee stock plans	1,517	139	606
Other financing activities	(3,826)	(15,715)	(11,670)
Net cash used in financing activities	(20,945)	(66,882)	(81,047)
Effect of exchange rate changes on cash	177	(212)	576
Net increase (decrease) in cash, cash equivalents, and restricted cash	(13,097)	(20,664)	13,840
Cash, cash equivalents, and restricted cash at beginning of year	18,237	38,901	25,061
Cash, cash equivalents, and restricted cash at end of year	$ 5,140	$ 18,237	$ 38,901